Search

everythinglearnresearchcommunity

for

Search:↓

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Wet cupping blood has different components than regular venous blood, which might affect skin disorder treatments.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Azathioprine can cause hair loss and matted hair.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Most trichological shampoo ingredients lack strong evidence for effectiveness against hair loss.

Extracellular vesicles can help repair and regenerate tissues with less risk of rejection.

Using adipose-derived stem cell media with minoxidil may help regrow hair in men with hair loss.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

New biological pathways and potential treatment targets for male pattern baldness were identified.

Electric stimulation at 448 kHz can promote hair growth by enhancing cell activity in hair follicles.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

Photobiomodulation effectively improves skin and hair conditions with minimal side effects.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Using 448-kHz Capacitive-Resistive Electrothermal Therapy can help increase hair density and prevent hair loss in women.

Higher aldosterone levels link to hair loss and high blood pressure.

Extracorporeal shock waves significantly improve hair growth in women with female pattern hair loss.

Men with severe early-onset baldness may have worse heart artery function and stiffer arteries if they have high blood pressure.

Hair loss in young men in Central India is linked to severe heart disease.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Mice with autoimmune hair loss showed signs of heart problems.

Young adults with hair loss face higher risk of stiff arteries.